ID

32232

Description

Study ID: 106218 Clinical Study ID: TDC106218 Study Title: Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride  Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: testosterone Trade Name: Andropatch,Androderm Study Indication: Hypogonadism, Male

Mots-clés

Versions (1)
  1. 24/10/2018 24/10/2018 -
Détendeur de droits

GSK group of companies

Téléchargé le

24 octobre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Bioavailability and Pharmacokinetics of Testosterone with/without Dutasteride - 106218

Anglais

Part 2: Repeat Dose Phase - Day 21 - Treatment confirmation

1 Formulaires  
Administrative data
Description

Administrative data

Subject Identifier
Description

Subject Identifier

Type de données

integer

Investigational Product
Description

Investigational Product

Planned Timepoint
Description

Planned Timepoint

Type de données

integer

Investigational Product
Description

Investigational Product

Type de données

text

Date of Dose
Description

Date of Dose

Type de données

date

Time of Dose
Description

Time of Dose

Type de données

time

Treatment Confirmation
Description

Treatment Confirmation

Did the subject receive the correct treatment (e.g, treatment which the subject was assigned to) during this dosing interval?
Description

Did the subject receive the correct treatment (e.g, treatment which the subject was assigned to) during this dosing interval?

Type de données

boolean

If NO, record reason(s)
Description

If NO, record reason(s)

Type de données

text

Retour au début de la page

Similar models

Part 2: Repeat Dose Phase - Day 21 - Treatment confirmation

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative data
Subject Identifier
Item
Subject Identifier
integer
Item Group
Investigational Product
Item
Planned Timepoint
integer
Planned Timepoint
Code List
Planned Timepoint
CL Item
Day 20 AM (1)
CL Item
Day 20 AM (2)
CL Item
Day 20 PM (3)
CL Item
Day 20 PM (4)
Item
Investigational Product
text
Investigational Product
Code List
Investigational Product
CL Item
Dustasteride (1)
CL Item
Testosterone (2)
CL Item
Dustasteride (3)
CL Item
Testosterone (4)
Date of Dose
Item
Date of Dose
date
Time of Dose
Item
Time of Dose
time
Item Group
Treatment Confirmation
Did the subject receive the correct treatment (e.g, treatment which the subject was assigned to) during this dosing interval?
Item
Did the subject receive the correct treatment (e.g, treatment which the subject was assigned to) during this dosing interval?
boolean
If NO, record reason(s)
Item
text
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial